The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvraz Regulatory News (EVR)

  • This share is currently suspended. It was suspended at a price of 82.52

Share Price Information for Evraz (EVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.52
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 82.52
EVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective

28 Dec 2022 08:30

EVRAZ plc (EVR)


EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective

28-Dec-2022 / 10:30 MSK

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

The issuer is solely responsible for the content of this announcement.


NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT OR THE CONSENT SOLICITATION MEMORANDUM.

EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective

London, 28 December 2022 – on 15 November 2022, EVRAZ plc (the “Issuer”) announced a consent solicitation in relation to the outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 issued by the Issuer (Regulation S Notes: Common Coder 184344327 / ISIN XS1843443273; Rule 144A Notes: Common Code 111730776 / ISIN US30052KAA79/ CUSIP 30052KAA7) (the “Notes”) on the terms and subject to the conditions set forth in the consent solicitation memorandum dated 15 November 2022 (the “Consent Solicitation Memorandum”). Capitalised terms used, but not defined herein, shall have the meanings given to them in the Consent Solicitation Memorandum.

The Issuer notifies that, on 23 December 2022, (i) the Issuer and the New Trustee entered into the Deed of Appointment to effectuate the Appointment; and (ii) the Issuer and the New Trustee entered into the Supplemental Trust Deed to effectuate the Amendments. Accordingly, the Appointment and the Amendments have become effective and binding on all Noteholders with effect from that date.

The Issuer extends its gratitude for the support and cooperation demonstrated by investors which has been reflected in the successful results of the Consent Solicitation.

 

 

Questions and requests for assistance in connection with the Consent Solicitation should be directed to the Information and Tabulation Agent:

Limited liability company “Legal Capital Investor Services”

Address:  10 Krivokolenny lane, bldg. 6, Moscow 101000, Russia

Email:   evraz@lcpis.ru

Phone:   +7 495 122 05 17

Website:  www.lcpis.ru

 

###

For further information:

 

Investor Relations

+7 495 232 1370

ir@evraz.com

 



ISIN: GB00B71N6K86, XS1533915721, XS1843443273,
Category Code: MSCL
TIDM: EVR
LEI Code: 5493005B7DAN39RXLK23
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.: 211143
EQS News ID: 1521415

 
End of Announcement EQS News Service


fncls.ssp?fn=show_t_gif&application_id=1521415&application_name=news&site_id=london_south_east
Date   Source Headline
29th May 20181:08 pmRNSTransaction announcement and GM notice
24th May 201812:09 pmRNSInterim dividend for 2018
14th May 20185:07 pmRNSDirector/PDMR Shareholding
14th May 20187:00 amRNSDirector/PDMR Shareholding
10th May 20186:00 pmRNSHolding(s) in Company
8th May 20188:43 amRNSNotice of 2018 AGM
4th May 201812:18 pmRNSTransfer of shares out of treasury, Voting rights
26th Apr 20187:00 amRNSEVRAZ Q1 2018 TRADING UPDATE
5th Apr 20187:00 amRNSDirector/PDMR Shareholding
16th Mar 20187:00 amRNSDirector/PDMR Shareholding
14th Mar 20189:51 amRNSDividend - Determination of Currency Amounts
13th Mar 20181:22 pmRNSDirector/PDMR Shareholding
5th Mar 20186:00 pmRNSAmendment of existing loan agreements
1st Mar 20188:53 amRNSTransaction announcement
1st Mar 20187:00 amRNSAnnual Financial Report
22nd Feb 201812:40 pmRNSNOTICE - FY2017 RESULTS, CONFERENCE CALL DETAILS
18th Jan 20187:00 amRNSQ4 and FY 2017 production report
18th Oct 20177:00 amRNSEVRAZ plc holds Investor Day
17th Oct 20177:00 amRNSQ3 2017 production report
26th Sep 20173:15 pmRNSDirector/PDMR Shareholding
14th Sep 201710:25 amRNSDirector/PDMR Shareholding
5th Sep 20175:13 pmRNSDirector/PDMR Shareholding
24th Aug 20172:57 pmRNSInterim Dividend Determination of Currency Amounts
10th Aug 20179:55 amRNSCorrection to Dividend Payment Currency Inform-on
10th Aug 20177:00 amRNSHalf-year Report
27th Jul 20176:00 pmRNSNOTICE - H1 2017 RESULTS & CONFERENCE CALL DETAILS
19th Jul 20177:00 amRNSQ2 2017 production report
20th Jun 201712:51 pmRNSResult of AGM
15th Jun 20174:16 pmRNSCompletion of disposal of Nakhodka Trade Sea Port
7th Jun 201711:33 amRNSEVRAZ supply chain transparency statement
2nd Jun 20172:30 pmRNSReport on payments to governments for 2016
31st May 20176:00 pmRNSTotal Voting Rights
26th May 20175:21 pmRNSTransaction announcement
23rd May 201710:42 amRNSResults of the General Meeting
15th May 20172:30 pmRNSNotice of 2017 AGM
12th May 20179:51 amRNSHolding(s) in Company - CORRECTED
11th May 20176:00 pmRNSHolding(s) in Company
11th May 201710:25 amRNSDirector/PDMR Shareholding
4th May 20177:00 amRNSTransfer of shares out of treasury, Voting rights
3rd May 20171:08 pmRNSPublication and Posting of Shareholder Circular
3rd May 20177:00 amRNSTransaction announcement
27th Apr 20177:00 amRNSEVRAZ - PARTIAL REDEMPTION OF 7.5% NOTES DUE 2019
20th Apr 20177:03 amRNSQ1 2017 production report
14th Mar 20177:00 amRNSEVRAZ priced U.S.$750 million note issue
1st Mar 20177:00 amRNSAnnual Financial Report
22nd Feb 20176:00 pmRNSNOTICE OF FY 2016 RESULTS
19th Jan 20177:00 amRNSQ4 and FY 2016 production report
3rd Jan 20171:00 pmRNSDirector/PDMR Shareholding (CORRECTED)
30th Dec 201612:39 pmRNSDirector/PDMR Shareholding
29th Dec 20161:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.